This inventor holds 2 USPTO granted patents. Top assignee: Richter Gedeon Vegyeszeti Gyar Rt. Active years: 1988-1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988-1989
Title: Anna Kassai Nee Zieger: Innovator in Pharmaceutical Chemistry
Introduction
Anna Kassai Nee Zieger is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative patents. With a total of 2 patents, her work focuses on the development of novel compounds with potential therapeutic applications.
Latest Patents
Anna's latest patents include groundbreaking inventions such as "2-Halogenated-8- and 1,8-substituted ergolenes." This invention relates to novel 2-halogenated 8- and 1,8-substituted ergolene derivatives, along with their acid addition salts and pharmaceutical compositions. The formula (I) describes these compounds, where X stands for a halogen. Another significant patent is the "Process for the preparation of an apovincaminol derivative." This invention outlines a new method for synthesizing 17,18-dehydro-apovincaminol-trimethoxy-benzoate, starting from specific vincamine derivatives and employing complex metal hydrides and acylation techniques.
Career Highlights
Anna Kassai Nee Zieger is associated with Richter Gedeon Vegyeszeti Gyar Rt, a leading pharmaceutical company in Hungary. Her work at this esteemed institution has allowed her to explore and develop innovative solutions in drug formulation and synthesis.
Collaborations
Throughout her career, Anna has collaborated with notable colleagues such as Tibor Keve and Bela Stefko. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Anna Kassai Nee Zieger is a remarkable inventor whose contributions to pharmaceutical chemistry are noteworthy. Her innovative patents and collaborations reflect her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
